Thomas H. Silberg
Vorsitzender bei GenWay Biotech, Inc.
Ursprung des Netzwerks ersten Grades von Thomas H. Silberg
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
Abraxis BioScience, Inc. /Old/
 Abraxis BioScience, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Abraxis BioScience, Inc. manufactures specialty pharmaceutical products. The company develops, manufactures and markets injectable products and leverages revolutionary technology such as its nab(TM) platform to discover and deliver breakthrough therapeutics that transform the treatment of cancer and other life threatening diseases. The company is located in Schaumburg, IL
28
| Extinct | Pharmaceuticals: Major | 28 |
| Public Company | Pharmaceuticals: Major | 18 | |
Fresenius Kabi Pharmaceuticals Holding LLC
 Fresenius Kabi Pharmaceuticals Holding LLC Pharmaceuticals: MajorHealth Technology Fresenius Kabi Pharmaceuticals Holding LLC is a pharmaceutical company, which engages in the development, manufacturing, and marketing of injectable pharmaceutical products. It primarily focuses on the injectable oncology, anti-infective, anesthetic/analgesic, and critical care markets. The firm manufactures products in each of the three basic forms, which include liquid, powder, and lyophilized or freeze-dried. Its products are generally used in hospitals, long-term care facilities, alternate care sites and clinics. The company was founded on July 2, 2008 and is headquartered in Wilmington, DE.
12
| Subsidiary | Pharmaceuticals: Major | 12 |
APP Pharmaceuticals, Inc.
 APP Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology APP Pharmaceuticals, Inc. develops, manufactures and markets injectable pharmaceutical products with a primary focus on the oncology, anti-infective, anesthetic/analgesic and critical care markets. It offers one of the most comprehensive product portfolios used in hospitals, long-term care facilities, alternate care sites and clinics within North America and manufactures a comprehensive range of dosage formulations. The company is headquartered in Los Angeles, CA.
11
| Subsidiary | Pharmaceuticals: Major | 11 |
Tercica, Inc.
 Tercica, Inc. Pharmaceuticals: MajorHealth Technology The Company's principal activity as a biopharmaceutical company is focused on the development and commercialization of products to improve endocrine health. Its first product, IncrelexTM (mecasermin {rDNA origin} injection), or recombinant human insulin-like growth factor-1 (rhIGF-1), is approved by the FDA for the treatment of severe Primary IGFD. The Company licensed the rights to develop, manufacture and commercialize Increlex from Genentech Inc.
9
| Extinct | Pharmaceuticals: Major | 9 |
GenWay Biotech, Inc.
 GenWay Biotech, Inc. Miscellaneous Commercial ServicesCommercial Services GenWay Biotech, Inc. operates as protein and antibody solutions provider. The firm has a proprietary technology platform and an international network to provide its clients with solutions and applications for proteins, antibodies, assays and cell lines. It specializes in recombinant proteins and domain-specific IgY (chicken) antibodies and its applications, such as Seppro products and difficult-to-express proteins. The company was founded by Wei-Wei Zhang in 1998 and is headquartered in San Diego, CA.
2
| Subsidiary | Miscellaneous Commercial Services | 2 |
Abraxis Pharmaceutical Products
 Abraxis Pharmaceutical Products Medical SpecialtiesHealth Technology Abraxis Pharmaceutical Products provides injectible pharmaceutical products. It offers anti-infective, critical care, oncology and anesthetic/analgesic products. The company is located in Schaumburg, IL.
1
| Subsidiary | Medical Specialties | 1 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Thomas H. Silberg
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
| INTERMUNE INC | Biotechnology | General Counsel General Counsel Corporate Officer/Principal Director/Board Member Director of Finance/CFO | |
| Purdue University | College/University | Undergraduate Degree Graduate Degree Undergraduate Degree Undergraduate Degree | |
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal General Counsel Corporate Officer/Principal Corporate Officer/Principal | |
| NANTHEALTH, INC. | Packaged Software | Founder Director/Board Member Director/Board Member Director/Board Member | |
| The University of Texas at Austin | College/University | Corporate Officer/Principal Undergraduate Degree Undergraduate Degree | |
| The University of North Carolina at Charlotte | College/University | Undergraduate Degree Doctorate Degree Graduate Degree | |
| Massachusetts Institute of Technology | College/University | Doctorate Degree Doctorate Degree Undergraduate Degree | |
| St. Louis University | College/University | Masters Business Admin Masters Business Admin | |
| University of California, Los Angeles | College/University | Corporate Officer/Principal Doctorate Degree | |
| University of Kansas | College/University | Undergraduate Degree Doctorate Degree | |
| LIMINAL BIOSCIENCES INC. | Biotechnology | Director/Board Member Director/Board Member | |
| CARDINAL HEALTH, INC. | Medical Distributors | Corporate Officer/Principal Corporate Officer/Principal | |
Cornell University
 Cornell University Other Consumer ServicesConsumer Services Cornell University is an educational institution that offers undergraduate and post graduate programs. It was founded in 1865 and is based in Ithaca, NY. | College/University | Undergraduate Degree Corporate Officer/Principal | |
Association for Accessible Medicines
 Association for Accessible Medicines Miscellaneous Commercial ServicesCommercial Services The Association for Accessible Medicines is an organization that aims to make generic and biosimilar medicines more accessible to those who need them. The organization is based in Arlington, VA. The non-profit company believes that increasing competition is the key to tackling the high cost of prescription drugs, rather than shifting costs among healthcare stakeholders. In 2022, generic and biosimilar prescription medicines saved $408 billion for the healthcare system overall, with more than $2.90 trillion saved over the past 10 years. The company was founded by Milan Puskar, Robert R. Grusky. David Gaugh has been the CEO of the company since 2012. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
Baxter Healthcare Corp.
 Baxter Healthcare Corp. Medical SpecialtiesHealth Technology Baxter Healthcare Corp. develops, manufactures, and distributes hospital supplies and medical technologies. It distributes medical treatment options for conditions such as hemophilia, immune disorders, kidney disease, cancer, and trauma. The company was founded on June 21, 1967 and is headquartered in Deerfield, IL. | Medical Specialties | Comptroller/Controller/Auditor Corporate Officer/Principal | |
| University of California San Diego | College/University | Undergraduate Degree Doctorate Degree | |
| University of Florida | College/University | Doctorate Degree Graduate Degree | |
| The University of Chicago | College/University | Masters Business Admin Doctorate Degree | |
Abraxis Health, Inc.
 Abraxis Health, Inc. BiotechnologyHealth Technology Abraxis Health is establishing as a fully-integrated, next-generation, evidence-based, and personalized healthcare company. It plans to develop a proprietary model for the delivery of healthcare. Abraxis Health is designing and acquiring the necessary infrastructure and plans to acquire and internally develop the hardware and software modules to organize and integrate the data streams that form the foundation of an interactive database. The firm will develop, test, and validate diagnostics and drugs to target pre-selected patients based on molecular profiles that predict drug response to particular therapeutics. | Biotechnology | Chief Executive Officer Chief Operating Officer | |
NantWorks LLC
 NantWorks LLC Information Technology ServicesTechnology Services NantWorks LLC develops technology based semiconductor and advanced networks for healthcare improvements. Its solution is for life threatening diseases such as cancer, infectious diseases and Alzheimer’s. The company was founded by Patrick Soon-Shiong in September 2011 and is headquartered in Culver City, CA. | Information Technology Services | Chief Executive Officer Corporate Officer/Principal | |
| OMNIAB, INC. | Miscellaneous Commercial Services | General Counsel Chief Tech/Sci/R&D Officer | |
| Ludwig-Maximilians-Universität München | College/University | Doctorate Degree Doctorate Degree | |
| University of Maryland | College/University | Corporate Officer/Principal Undergraduate Degree | |
Hoffmann-La Roche, Inc.
 Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Hoffmann-La Roche, Inc. manufactures pharmaceutical drugs. Its products include influenza fighter Tamiflu, controversial acne medication Accutane, HIV inhibitor Fuzeon, obesity drug Xenical, and hepatitis C therapy Pegasys. The company was founded in 1896 Roche and is headquartered in Nutley, NJ. | Biotechnology | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| University of Oklahoma | College/University | Graduate Degree Doctorate Degree | |
Eli Lilly Canada, Inc.
 Eli Lilly Canada, Inc. Pharmaceuticals: MajorHealth Technology Part of Eli Lilly & Co., Eli Lilly Canada, Inc. is a healthcare leader that focuses on oncology, diabetes, autoimmunity, neurodegeneration, and pain. The company is based in Scarborough, Canada. Established in 1938, the Canadian company collaborates with scientists to produce innovative medicines that make life better for people around the world. The company's mission is to discover and bring life-changing medicines to people who need them, improve the understanding and management of disease, and contribute to communities through philanthropy and volunteerism. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
ProMetic BioTherapeutics, Inc.
 ProMetic BioTherapeutics, Inc. BiotechnologyHealth Technology Part of KEDRION HOLDING S.P.A., ProMetic BioTherapeutics, Inc. is a company that manufactures plasma protein fractionation products. The company is based in Rockville, MD. ProMetic BioTherapeutics was acquired by Kedrion Biopharma, Inc. on October 18, 2021. | Biotechnology | Corporate Officer/Principal Chief Operating Officer | |
| The California State University | College/University | Masters Business Admin Undergraduate Degree | |
American Society of Clinical Oncology, Inc.
 American Society of Clinical Oncology, Inc. Medical/Nursing ServicesHealth Services The American Society of Clinical Oncology is a non-profit organization founded in 1964 with the overarching goals of improving cancer care and prevention. More than 27,000 oncology practitioners belong to ASCO, representing all oncology disciplines and subspecialties. Members include physicians and health-care professionals in all levels of the practice of oncology. American Society of Clinical Oncology is the world’s leading professional organization representing physicians who treat people with cancer. ASCO’s members set the standard for patient care worldwide and lead the way in carrying out clinical research aimed at improving the prevention, diagnosis, and treatment of cancer. ASCO's efforts are also directed toward advocating for policies that provide access to high-quality care for all patients with cancer and at supporting the increased funding for clinical and translational research. | Medical/Nursing Services | Corporate Officer/Principal Corporate Officer/Principal | |
| IMMUNITYBIO, INC. | Pharmaceuticals: Major | Founder Director/Board Member | |
| University of London | College/University | Doctorate Degree Undergraduate Degree | |
| University of Cambridge | College/University | Undergraduate Degree Graduate Degree | |
| The University of Colorado | College/University | Graduate Degree Undergraduate Degree | |
| University of Michigan | College/University | Doctorate Degree Graduate Degree | |
| FRESENIUS KABI ONCOLOGY LTD | Miscellaneous Commercial Services | Director/Board Member Chief Tech/Sci/R&D Officer | |
Viracta Subsidiary, Inc.
 Viracta Subsidiary, Inc. BiotechnologyHealth Technology Viracta Subsidiary, Inc. engages in the development of proprietary viral gene activation therapy to address cancers associated with the Epstein-Barr virus. Its platform is designed as a targeted approach to treat a range of viral-associated cancers and other serious diseases. The company was founded by Ronald J. Berenson, Douglas V. Faller, George C. Hillman, Thalia Papayannopoulou, Susan P. Perrine, George Stamatoyannopoulos, and Robert Williams and is headquartered in Cardiff, CA. | Biotechnology | Director/Board Member Director/Board Member | |
| Stanford University | College/University | Graduate Degree Undergraduate Degree | |
Lyon & Lyon, Inc.
 Lyon & Lyon, Inc. Miscellaneous Commercial ServicesCommercial Services Lyon & Lyon, Inc. engages in the provision of legal services. The company was founded on September 4, 1979 and is headquartered in San Diego, CA. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
| Harvard Business School | College/University | Masters Business Admin Masters Business Admin | |
Orchid Cellmark, Inc.
 Orchid Cellmark, Inc. Miscellaneous Commercial ServicesCommercial Services Orchid Cellmark, Inc. provides DNA testing services. It generates genetic profile information by analysing an organism's unique genetic identity. The firm also offers non-DNA forensic laboratory services. The company was founded on March 8, 1995 and is headquartered in Princeton, NJ. | Miscellaneous Commercial Services | Director/Board Member | |
| Laudus Trust | Investment Trusts/Mutual Funds | Director/Board Member | |
| The Nicklin Capital Group, Inc. | Founder | ||
| Schwab Funds | Investment Trusts/Mutual Funds | Director/Board Member |
Statistik
International
| Vereinigte Staaten | 44 |
| Kanada | 3 |
| Vereinigtes Königreich | 3 |
| Spanien | 2 |
| Deutschland | 2 |
Sektoral
| Consumer Services | 21 |
| Health Technology | 17 |
| Commercial Services | 6 |
| Technology Services | 3 |
| Miscellaneous | 3 |
Operativ
| Director/Board Member | 195 |
| Corporate Officer/Principal | 163 |
| Undergraduate Degree | 59 |
| Chairman | 56 |
| Chief Tech/Sci/R&D Officer | 51 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Patrick Soon-Shiong | 52 |
| Thomas Wiggans | 31 |
| Michael Blaszyk | 24 |
| Kirk Calhoun | 23 |
| Wayne T. Hockmeyer | 22 |
| John Kozarich | 21 |
| David Chen | 21 |
| David Mahoney | 21 |
| Bruce Wendel | 19 |
| Bernhard Hampl | 17 |
| Timothy Patrick Lynch | 16 |
| Michael J. Brunelle | 15 |
| Carlo Montagner | 13 |
| Richard Ghalie | 13 |
| Charles Berkman | 12 |
- Börse
- Insiders
- Thomas H. Silberg
- Unternehmensverbindungen
